Explore
Validate
Learn
Western blot
ImmunohistochemistryAntibody data
- Antibody Data
- Antigen structure
- References [11]
- Comments [0]
- Validations
- Immunohistochemistry [1]
Submit
Validation data
Reference
Comment
Report error
- Product number
- 11456-1-AP - Provider product page
- Provider
- Proteintech Group
- Proper citation
- Proteintech Cat#11456-1-AP, RRID:AB_2269940
- Product name
- S100A16 antibody
- Antibody type
- Polyclonal
- Description
- S100A16 antibody (Cat. #11456-1-AP) is a rabbit polyclonal antibody that shows reactivity with human and has been validated for the following applications: IF, IHC, WB,ELISA.
- Reactivity
- Human
- Host
- Rabbit
- Conjugate
- Unconjugated
- Isotype
- IgG
- Vial size
- 20ul, 150ul
Submitted references Calcium Binding Protein S100A16 Expedites Proliferation, Invasion and Epithelial-Mesenchymal Transition Process in Gastric Cancer.
S100A16 suppresses the proliferation, migration and invasion of colorectal cancer cells in part via the JNK/p38 MAPK pathway.
ADAMTS19 Suppresses Cell Migration and Invasion by Targeting S100A16 via the NF-κB Pathway in Human Gastric Cancer.
Interaction of calcium binding protein S100A16 with myosin-9 promotes cytoskeleton reorganization in renal tubulointerstitial fibrosis.
Brain microvascular endothelial cell exosome-mediated S100A16 up-regulation confers small-cell lung cancer cell survival in brain.
S100A16 is a prognostic marker for colorectal cancer.
Differentially expressed genes in preimplantation human embryos: potential candidate genes for blastocyst formation and implantation.
S100A16 promotes differentiation and contributes to a less aggressive tumor phenotype in oral squamous cell carcinoma.
Co-expression of S100A14 and S100A16 correlates with a poor prognosis in human breast cancer and promotes cancer cell invasion.
S100A14 interacts with S100A16 and regulates its expression in human cancer cells.
S100A16 mediation of weight gain attenuation induced by dietary calcium.
You X, Li M, Cai H, Zhang W, Hong Y, Gao W, Liu Y, Liang X, Wu T, Chen F, Su D
Frontiers in cell and developmental biology 2021;9:736929
Frontiers in cell and developmental biology 2021;9:736929
S100A16 suppresses the proliferation, migration and invasion of colorectal cancer cells in part via the JNK/p38 MAPK pathway.
Ou S, Liao Y, Shi J, Tang J, Ye Y, Wu F, Wang W, Fei J, Xie F, Bai L
Molecular medicine reports 2021 Feb;23(2)
Molecular medicine reports 2021 Feb;23(2)
ADAMTS19 Suppresses Cell Migration and Invasion by Targeting S100A16 via the NF-κB Pathway in Human Gastric Cancer.
Jiang Y, Yu X, Zhao Y, Huang J, Li T, Chen H, Zhou J, Huang Z, Yang Z
Biomolecules 2021 Apr 12;11(4)
Biomolecules 2021 Apr 12;11(4)
Interaction of calcium binding protein S100A16 with myosin-9 promotes cytoskeleton reorganization in renal tubulointerstitial fibrosis.
Sun H, Zhao A, Li M, Dong H, Sun Y, Zhang X, Zhu Q, Bukhari AA, Cao C, Su D, Liu Y, Liang X
Cell death & disease 2020 Feb 24;11(2):146
Cell death & disease 2020 Feb 24;11(2):146
Brain microvascular endothelial cell exosome-mediated S100A16 up-regulation confers small-cell lung cancer cell survival in brain.
Xu ZH, Miao ZW, Jiang QZ, Gan DX, Wei XG, Xue XZ, Li JQ, Zheng F, Qin XX, Fang WG, Chen YH, Li B
FASEB journal : official publication of the Federation of American Societies for Experimental Biology 2019 Feb;33(2):1742-1757
FASEB journal : official publication of the Federation of American Societies for Experimental Biology 2019 Feb;33(2):1742-1757
S100A16 is a prognostic marker for colorectal cancer.
Sun X, Wang T, Zhang C, Ning K, Guan ZR, Chen SX, Hong TT, Hua D
Journal of surgical oncology 2018 Feb;117(2):275-283
Journal of surgical oncology 2018 Feb;117(2):275-283
Differentially expressed genes in preimplantation human embryos: potential candidate genes for blastocyst formation and implantation.
Munch EM, Sparks AE, Gonzalez Bosquet J, Christenson LK, Devor EJ, Van Voorhis BJ
Journal of assisted reproduction and genetics 2016 Aug;33(8):1017-25
Journal of assisted reproduction and genetics 2016 Aug;33(8):1017-25
S100A16 promotes differentiation and contributes to a less aggressive tumor phenotype in oral squamous cell carcinoma.
Sapkota D, Bruland O, Parajuli H, Osman TA, Teh MT, Johannessen AC, Costea DE
BMC cancer 2015 Sep 9;15:631
BMC cancer 2015 Sep 9;15:631
Co-expression of S100A14 and S100A16 correlates with a poor prognosis in human breast cancer and promotes cancer cell invasion.
Tanaka M, Ichikawa-Tomikawa N, Shishito N, Nishiura K, Miura T, Hozumi A, Chiba H, Yoshida S, Ohtake T, Sugino T
BMC cancer 2015 Feb 13;15:53
BMC cancer 2015 Feb 13;15:53
S100A14 interacts with S100A16 and regulates its expression in human cancer cells.
Sapkota D, Costea DE, Ibrahim SO, Johannessen AC, Bruland O
PloS one 2013;8(9):e76058
PloS one 2013;8(9):e76058
S100A16 mediation of weight gain attenuation induced by dietary calcium.
Zhang R, Zhu W, Du X, Xin J, Xue Y, Zhang Y, Li D, Liu Y
Metabolism: clinical and experimental 2012 Feb;61(2):157-63
Metabolism: clinical and experimental 2012 Feb;61(2):157-63
No comments: Submit comment
Supportive validation
- Submitted by
- Proteintech Group (provider)
- Main image
- Experimental details
- The S100A16 antibody from Proteintech is a rabbit polyclonal antibody to a recombinant protein of human S100A16. This antibody recognizes human, mouse, rat antigen. The S100A16 antibody has been validated for the following applications: ELISA, IHC analysis.
